bay-k-8644 has been researched along with mibefradil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, K; Hermsmeyer, K | 1 |
| Birnbaumer, L; Hofmann, F; Ito, H; Klugbauer, N; Lacinová, L; Schuster, A | 1 |
| Brust, PF; Hans, M; Harpold, MM; Prodanovich, P; Stauderman, KA; Urrutia, A; Washburn, MS; Williams, ME | 1 |
| Fagard, R; Lijnen, P; Petrov, V | 1 |
| Balfagón, G; Encabo, A; Ferrer, M; Manso, AM; Marín, J; Salaices, M | 1 |
| Ahn, JS; Cho, KW; Cui, X; Kim, SH; Kim, SZ; Lee, HS; Park, YK; Seul, KH; Wen, JF | 1 |
| Kim, YC; Koh, SD; Sanders, KM | 1 |
| Champagne, S; Crozatier, B; Ennezat, PV; Heloire, F; Hittinger, L; Houel, R; Sambin, L; Su, JB; Suto, Y | 1 |
| Bahí, N; Cantí, C; Das, A; Herreros, J; Martí, RM; Matias-Guiu, X; Pamplona, R; Pushparaj, C; Sorolla, A; Vilella, R | 1 |
9 other study(ies) available for bay-k-8644 and mibefradil
| Article | Year |
|---|---|
Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzimidazoles; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dogs; Electrophysiology; Membrane Potentials; Mibefradil; Muscle, Smooth, Vascular; Tetrahydronaphthalenes | 1993 |
The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amino Acid Sequence; Benzimidazoles; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Humans; Ion Channel Gating; Isradipine; Mibefradil; Molecular Sequence Data; Muscle Proteins; Protein Structure, Tertiary; Recombinant Fusion Proteins; Sequence Alignment; Structure-Activity Relationship; Tetrahydronaphthalenes; Transfection; Verapamil | 1996 |
Structure and functional characterization of a novel human low-voltage activated calcium channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Barium; Benzimidazoles; Blotting, Northern; Cadmium; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, T-Type; Cells, Cultured; Cloning, Molecular; Diuretics; DNA, Complementary; Electric Stimulation; Electrophysiology; Humans; Ion Channel Gating; Kidney; Kinetics; Membrane Potentials; Mibefradil; Molecular Sequence Data; Nickel; Nimodipine; Oocytes; Recombinant Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Tetrahydronaphthalenes; Transcription, Genetic; Verapamil; Xenopus | 1999 |
Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cell Division; Gallic Acid; Humans; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Mibefradil; Nifedipine; Receptors, Interleukin-2; Tetrahydronaphthalenes; Time Factors | 1999 |
Changes of cardiac calcium homeostasis in spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Electric Stimulation; Heart Ventricles; Homeostasis; Hypertension; In Vitro Techniques; Isoproterenol; Male; Mibefradil; Myocardial Contraction; Myocardium; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ryanodine | 1999 |
Distinct roles for L- and T-type Ca(2+) channels in regulation of atrial ANP release.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atrial Natriuretic Factor; Bodily Secretions; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Diltiazem; Extracellular Space; Heart Atria; In Vitro Techniques; Mibefradil; Myocardial Contraction; Myocardium; Rabbits; Stroke Volume | 2000 |
Voltage-dependent inward currents of interstitial cells of Cajal from murine colon and small intestine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cells, Cultured; Colon; Dihydropyridines; Electrophysiology; In Vitro Techniques; Intestine, Small; Ion Channel Gating; Membrane Potentials; Mibefradil; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Muscle, Smooth; Nickel; Patch-Clamp Techniques; Sodium | 2002 |
Different effects of mibefradil and amlodipine on coronary vessels and during beta-adrenergic stimulation in conscious dogs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dogs; Drug Interactions; Electric Stimulation; Hemodynamics; Male; Mibefradil | 2002 |
Functional expression of voltage-gated calcium channels in human melanoma.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Cell Survival; Flow Cytometry; Fura-2; Gene Expression Regulation, Neoplastic; Humans; Manganese; Melanocytes; Melanoma; Mibefradil; Molecular Imaging; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Up-Regulation | 2012 |